CIK 0001822791
- Non-accelerated filer
- Smaller reporting company
Clene Inc.
Sign in to watch- Ticker
- CLNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 852828339
- Phone
- +1 801-676-9695
- Business address
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
- Former names
- Chelsea Worldwide Inc.
- 4 Open-market buy Director bought 149,610 shares at an average $2.50 ($374,771)
- 4 Open-market sale Chief Science Officer sold 20,247 shares at $2.47 ($50,010)
- 4 Open-market buy Director bought 5,000 shares at $2.62 ($13,100)
- 4 Open-market buy Director bought 96,011 shares at $2.66 ($255,389)
- 4 Open-market buy Director bought 55,000 shares at $3.06 ($168,300)
- 4 Open-market buy Director bought 60,670 shares at an average $2.55 ($154,822)
- 4 Open-market buy Director bought 35,000 shares at $2.27 ($79,450)
- 4 Open-market sale 10% owner sold 181,818 shares at $2.20 ($400,000)
- 4 Open-market buy Director bought 181,818 shares at $2.20 ($400,000)
- 4 Open-market sale Chief Medical Officer sold 4,717 shares at $2.03 ($9,576)
- 4 Open-market buy Director bought 10,000 shares at $2.08 ($20,800)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 100,000 shares (option exercise)
- 4 Open-market sale 10% owner sold 132,891 shares at $3.01 ($400,002)
Page 13 of 19 · 368 filings